节点文献

英菲格拉替尼的合成工艺研究

Synthesis process study of inflaglatinib

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 任乐吴越钟树诚张扬孙雨薇赵燕芳侯云雷

【Author】 REN Le;WU Yue;ZHONG Shucheng;ZHANG Yang;SUN Yuwei;ZHAO Yanfang;HOU Yunlei;School of Pharmaceutical Engineering, Shenyang Pharmaceutical University;School of Medical Equipment, Shenyang Pharmaceutical University;

【通讯作者】 赵燕芳;侯云雷;

【机构】 沈阳药科大学制药工程学院沈阳药科大学医疗器械学院

【摘要】 目的 优化英菲格拉替尼的合成路线。方法 以对氟硝基苯为起始原料,经与N-乙基哌嗪亲核取代、还原反应得中间体4-(4-乙基哌嗪-1-基)苯胺(4); 4,6-二氯嘧啶与甲胺经亲核取代反应得中间体6-氯-4-甲胺基嘧啶(5);中间体4与中间体5经亲核取代反应得中间体N-[4-(4-乙基哌嗪-1-基)苯基]-N’-甲基嘧啶-4,6-二胺(6);以3,5-二甲氧基苯胺为另一起始原料,依次经乙酰基保护、氯代、脱保护基反应后与氯甲酸苯酯缩合得中间体(2,6-二氯-3,5-二甲氧基苯基)氨基甲酸苯酯(10)。中间体6与10经亲核取代反应制得目标产物英菲格拉替尼。结果 英菲格拉替尼的化学结构经M S、1H-NM R、13C-NM R及IR确证,总收率达到49.6%(以化合物2计),纯度达到99.38%(HPLC面积归一化法)。结论该工艺所采用的合成路线原料廉价易得,反应条件温和,整条路线避免了柱色谱方法纯化,后处理简单且绿色环保,所得中间体及目标产物纯度较高,为工业化生产奠定了基础。

【Abstract】 Objective To optimize the tw o synthetic routes for infigratinib involves tw o parallel pathw ays starting from distinct raw materials. Methods In the first pathw ay,4-fluoronitrobenzene underw ent nucleophilic substitution w ith N-ethylpiperazine follow ed by reduction to generate intermediate 4-( 4-ethylpiperazin-1-yl) aniline( 4). Simultaneously,4,6-dichloropyrimidine reacted w ith methylamine via nucleophilic substitution to yield 6-chloro-4-( methylamino) pyrimidine( 5). These tw o intermediates( 4 and 5) w ere then coupled through nucleophilic substitution to form N-[4-( 4-ethylpiperazin-1-yl) phenyl]-N’-methylpyrimidine-4,6-diamine( 6). In the second pathw ay,3,5-dimethoxyaniline w ere sequentially subjected to acetylation protection,chlorination,deprotection,and condensation w ith phenyl chloroformate,ultimately produced intermediate( 2,6-dichloro-3,5-dimethoxyphenyl) carbamic acid phenyl ester( 10). The final step involved nucleophilic substitution betw een intermediates 6 and 10 to afford the target compound infigratinib. Results The chemical structure of infigratinib w as confirmed by M S,1H-NM R,13C-NM R,and IR spectroscopy,achieving a total yield of 49. 6%( based on compound 2) and a purity of99. 38%( HPLC area normalization). Conclusion This synthetic route demonstrates significant advantages,including the use of low-cost and readily available starting materials,mild reaction conditions,elimination of column chromatography for purification,simplified post-processing procedures,and high purity of intermediates and the final product,thereby laying a robust foundation for industrial-scale production.

【关键词】 英菲格拉替尼合成工艺优化
【Key words】 infigratinibsynthesisprocess optimization
【基金】 沈阳药科大学大学生创新创业训练计划项目(202410163023)
  • 【文献出处】 沈阳药科大学学报 ,Journal of Shenyang Pharmaceutical University , 编辑部邮箱 ,2025年08期
  • 【分类号】R914;TQ460.6
  • 【下载频次】20
节点文献中: 

本文链接的文献网络图示:

本文的引文网络